Peter Crowley joined MTS Health Partners, which makes equity investments in companies within the services sectors of the health care industry, in 2011 as an Operating Partner. Additionally, since April 2008, he has been an operating partner at JH Partners, a private equity firm managing close to $1 billion of institutional funds. Crowley has been involved with JH Partners for more than 14 years as both a director of portfolio companies and an investor. Prior to 2011, Crowley spent 23 years at CIBC World Markets, with the last 14 years as global head of health care investment banking. Transactions include public and private equity, debt financings and mergers and acquisitions transactions for biotechnology, pharmaceutical, specialty pharmaceutical, generics, medical devices, health care services and technology companies.
Crowley sits on the board of several private companies, including Medical Knowledge Group, Ouidad and Gruppo Chiarello. He is also chairman of the public biotech company Progenics Pharmaceuticals. He is also a board member of the Foundation Fighting Blindness, a committee member of the Harvard Alumni Association and a council member of Rockefeller University. Crowley graduated from Harvard College in 1981 and received a MBA from Columbia University in 1985.